Every spring, as the first warm weekends bring people outdoors, a wave of patients arrive at pharmacy counters with an itchy, bumpy rash on sun-exposed skin. Many describe it as a "sun allergy." In most cases, they are right — polymorphic light eruption (PLE) is the most common photodermatosis in the UK, affecting an estimated 10–15% of the population according to the British Association of Dermatologists.
What PLE looks like
The term "polymorphic" reflects the condition's variable appearance. The rash can present as:
- Small, itchy red bumps (papules) — the most common form
- Raised, fluid-filled blisters (vesicles)
- Flat red patches (plaques)
- A combination of these
Key features that distinguish PLE from sunburn or other rashes:
| Feature | PLE | Sunburn | Drug photosensitivity |
|---|---|---|---|
| Timing after sun exposure | Hours to days | 4–6 hours | Hours to days |
| Distribution | Exposed areas spared in winter (arms, chest, legs) | All exposed areas | All exposed areas |
| Itch | Prominent | Burning/pain predominates | Variable |
| Recurrence | Same pattern each spring/summer | Not pattern-recurring | Linked to medication use |
| Natural hardening | Improves as summer progresses | No | No |
The most distinctive feature is seasonal onset: PLE typically appears after the first significant sun exposure of the year and tends to improve — or even resolve — as the summer continues. This "hardening" effect occurs as the skin develops tolerance to UV radiation over successive exposures.
Who gets it
PLE is more common in women than men (approximately 2:1 ratio) and typically starts in the teens or twenties. It can run in families. Fair-skinned individuals are more commonly affected, but PLE occurs across all skin types. People with darker skin may develop PLE that appears as more subtle hyperpigmented patches rather than the classic red papular rash.
Patients who cover up for most of the year and then have intense sun exposure on holiday are particularly susceptible — the "first sun of the holiday" rash is a classic PLE presentation.
Pharmacy management
Prevention
Sun protection is the cornerstone of PLE management. Pharmacy teams should recommend:
High-factor, broad-spectrum sunscreen. PLE is triggered primarily by UVA radiation (which penetrates cloud and glass), so a sunscreen with high UVA protection is essential. Look for products with a UVA star rating of 4 or 5, or those meeting the EU "UVA circle" standard. SPF 30 or higher is recommended.
Gradual sun exposure. Patients can build their own "hardening" by gradually increasing sun exposure time over the first weeks of spring. Starting with 15–20 minutes and adding 5–10 minutes per session over several days allows the skin to develop tolerance while minimising the risk of a flare.
Protective clothing. Long sleeves, wide-brimmed hats, and UV-protective fabrics are effective. Patients who know they are susceptible should cover up during peak UV hours (11am–3pm BST) in the first weeks of the season.
Treatment of a flare
When PLE has already developed, the following OTC treatments can help:
| Treatment | How it helps | Notes |
|---|---|---|
| Hydrocortisone 1% cream | Reduces inflammation and itch | Apply twice daily for up to 7 days to affected areas. Not for face unless GP-directed |
| Oral antihistamine (cetirizine, loratadine) | Reduces itch | Will not treat the rash itself but improves comfort |
| Cooling emollients | Soothes inflamed skin | Calamine lotion or after-sun with aloe vera |
| Sun avoidance | Prevents worsening | The rash will not settle while exposure continues |
Most PLE flares resolve within 7–10 days without scarring once sun exposure is reduced.
When to refer
Routine GP referral:
- Severe PLE that does not respond to sun avoidance and OTC treatment
- PLE that significantly limits the patient's ability to go outdoors (affects quality of life)
- Diagnostic uncertainty — the differential includes lupus erythematosus, solar urticaria, and drug-induced photosensitivity, all of which need medical assessment
Points for the GP: Patients with severe PLE may be offered prophylactic phototherapy (controlled UVB exposure in a hospital dermatology unit before summer) to build tolerance, or short courses of oral prednisolone for holiday cover. Some dermatologists prescribe hydroxychloroquine for recurrent severe PLE.
The pharmacy conversation
"This sounds like it could be polymorphic light eruption — it is very common and usually harmless, but it can be uncomfortable. The best prevention is a high-UVA sunscreen applied before you go out, and building up your sun exposure gradually rather than all at once. For the itch, a mild steroid cream and an antihistamine will help. If it is severe or keeps happening despite sun protection, your GP can arrange specialist assessment."
This positions the pharmacy as the first port of call for sun-related skin conditions and creates an opportunity to recommend appropriate sun protection products.
PharmSee's pharmacy finder can help patients locate pharmacies stocking specialist sunscreens, and pharmacists can explore salary data for dermatology-focused roles in the NHS.
Key points
- PLE is the UK's most common sun-sensitivity condition, affecting 10–15% of the population
- It typically appears after the first significant sun exposure of the year and improves with gradual hardening
- Prevention: high-UVA sunscreen (SPF 30+), gradual exposure, protective clothing
- Treatment: hydrocortisone cream, oral antihistamines, sun avoidance
- Refer if severe, recurrent, or diagnostically uncertain — differential includes lupus and solar urticaria
Sources: NICE CKS (Photosensitivity), BAD (Polymorphic light eruption), NHS (Polymorphic light eruption). Article reflects guidance current as of April 2026.